Black lung benefits for miners

Organic solvents and Multiple Sclerosis: the doubled risk dilemma.

Occupational medicine (Oxford, England)·2023

Death in the New Town: Edinburgh's hidden story of stonemasons' silicosis.

The journal of the Royal College of Physicians of Edinburgh·2018

Can we reduce the risk of dementia?

QJM : monthly journal of the Association of Physicians·2014

Breastfeeding and introduction of complementary foods during infancy in relation to the risk of asthma and atopic diseases up to 10 years.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2013

Inhibition of constitutive and cxc-chemokine-induced NF-kappaB activity potentiates ansamycin-based HSP90-inhibitor cytotoxicity in castrate-resistant prostate cancer cells.

British journal of cancer·2009

Dexamethasone potentiates the antiangiogenic activity of docetaxel in castration-resistant prostate cancer.

British journal of cancer·2008

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Genome-wide identification, evolutionary dynamics, and abiotic stress response networks of the magnesium transporter gene family in foxtail millet (Setaria italica L.).

Frontiers in plant science·2026

First evidence of keratinolytic activity in Simplicillium aogashimaense isolated from wool-pellet-amended soil.

Microbial cell factories·2026

Functional instant tea from black tea waste fiber: effects of extraction conditions on bioactive composition and in vitro anticancer activity.

Frontiers in nutrition·2026

Advanced beneficiation of quartz ore for high-purity silica production.

Scientific reports·2026

Enhanced uranium immobilization from carbonate-rich water by Bacillus pasteurii via protein-induced phosphate biomineralization.

Water research·2026

Erratum: Advancing hypoparathyroidism treatment: FDA approval of Palopegteriparatide as a promising orphan drug: Erratum.

Annals of medicine and surgery (2012)·2026

Related Experiment Videos

Black lung benefits for miners

Related Concept Videos

Organic solvents and Multiple Sclerosis: the doubled risk dilemma.

Death in the New Town: Edinburgh's hidden story of stonemasons' silicosis.

Can we reduce the risk of dementia?

Breastfeeding and introduction of complementary foods during infancy in relation to the risk of asthma and atopic diseases up to 10 years.

Inhibition of constitutive and cxc-chemokine-induced NF-kappaB activity potentiates ansamycin-based HSP90-inhibitor cytotoxicity in castrate-resistant prostate cancer cells.

Dexamethasone potentiates the antiangiogenic activity of docetaxel in castration-resistant prostate cancer.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Genome-wide identification, evolutionary dynamics, and abiotic stress response networks of the magnesium transporter gene family in foxtail millet (Setaria italica L.).

First evidence of keratinolytic activity in Simplicillium aogashimaense isolated from wool-pellet-amended soil.

Functional instant tea from black tea waste fiber: effects of extraction conditions on bioactive composition and in vitro anticancer activity.

Advanced beneficiation of quartz ore for high-purity silica production.

Enhanced uranium immobilization from carbonate-rich water by Bacillus pasteurii via protein-induced phosphate biomineralization.

Erratum: Advancing hypoparathyroidism treatment: FDA approval of Palopegteriparatide as a promising orphan drug: Erratum.

Related Experiment Videos

Black lung benefits for miners

Related Concept Videos

Related Articles